相似文献
1
Kaposi's sarcoma responding to topical imiquimod 5% cream: a case report.
Cases J. 2009 Sep 17;2:7092. doi: 10.1186/1757-1626-0002-0000007092.
2
Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.
J Am Acad Dermatol. 2008 Apr;58(4):585-91. doi: 10.1016/j.jaad.2007.11.005. Epub 2008 Feb 20.
3
Topical imiquimod 5% as a treatment for localized genital Kaposi's sarcoma in an HIV-negative man: a case report.
Int J STD AIDS. 2012 Dec;23(12):907-8. doi: 10.1258/ijsa.2012.012074.
4
Failed Treatment of Classic Kaposi's Sarcoma with Topical Timolol: Case Report and Review of the Literature.
Cureus. 2019 Dec 2;11(12):e6272. doi: 10.7759/cureus.6272.
5
Classic Kaposi's sarcoma - complete response to radiation therapy: a case report.
J Med Case Rep. 2016 Nov 10;10(1):322. doi: 10.1186/s13256-016-1101-6.
6
Classic Kaposi's sarcoma: low-dose interferon alfa treatment.
Dermatology. 1998;197(1):37-42. doi: 10.1159/000017973.
7
Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
AIDS. 2009 Sep 10;23(14):1918-22. doi: 10.1097/QAD.0b013e3283300a91.
8
Kaposi's sarcoma in association with Behcet's disease: case report and literature review.
Semin Arthritis Rheum. 2007 Apr;36(5):328-31. doi: 10.1016/j.semarthrit.2006.11.001. Epub 2007 Jan 22.
9
Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
J Invest Dermatol. 2001 Oct;117(4):858-63. doi: 10.1046/j.0022-202x.2001.01465.x.
10
Kaposi's sarcoma revisited.
AIDS Rev. 2007 Oct-Dec;9(4):230-6.
引用本文的文献
1
Topical treatments for Kaposi sarcoma: A systematic review.
Skin Health Dis. 2022 Apr 8;2(2):e107. doi: 10.1002/ski2.107. eCollection 2022 Jun.
2
Failed Treatment of Classic Kaposi's Sarcoma with Topical Timolol: Case Report and Review of the Literature.
Cureus. 2019 Dec 2;11(12):e6272. doi: 10.7759/cureus.6272.
3
Intralesional 3% sodium tetradecyl sulfate for treatment of cutaneous Kaposi's sarcoma.
Yonsei Med J. 2015 Jan;56(1):307-8. doi: 10.3349/ymj.2015.56.1.307.
本文引用的文献
1
Treatment of classic Kaposi's sarcoma with topical imiquimod.
Dermatol Surg. 2009 Jan;35(1):147-9. doi: 10.1111/j.1524-4725.2008.34397.x. Epub 2008 Dec 6.
2
Update on classic Kaposi sarcoma therapy: new look at an old disease.
Crit Rev Oncol Hematol. 2008 Dec;68(3):242-9. doi: 10.1016/j.critrevonc.2008.06.007. Epub 2008 Jul 25.
3
Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.
J Am Acad Dermatol. 2008 Apr;58(4):585-91. doi: 10.1016/j.jaad.2007.11.005. Epub 2008 Feb 20.
4
[Update on Kaposi's sarcoma].
Med Trop (Mars). 2007 Apr;67(2):123-30.
5
Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream.
Int J Dermatol. 2006 Jul;45(7):854-6. doi: 10.1111/j.1365-4632.2006.02829.x.
6
Imiquimod for actinic keratosis: systematic review and meta-analysis.
J Invest Dermatol. 2006 Jun;126(6):1251-5. doi: 10.1038/sj.jid.5700264.
7
Immunomodulatory and pharmacologic properties of imiquimod.
J Am Acad Dermatol. 2000 Jul;43(1 Pt 2):S6-11. doi: 10.1067/mjd.2000.107808.
8
Treatment of genital warts with an immune-response modifier (imiquimod).
J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):230-9. doi: 10.1016/s0190-9622(98)70243-9.
Zotero 插件